Article metrics

Download PDFPDF

380 Preliminary results of an ongoing phase I trial of FT500, a first-in-class, off-the-shelf, induced pluripotent stem cell (iPSC) derived natural killer (NK) cell therapy in advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2020 to April 2022

AbstractFullPdf
Nov 2020348042
Dec 2020112015
Jan 202178016
Feb 202192010
Mar 202194014
Apr 2021170023
May 202153029
Jun 20210017
Jul 2021009
Aug 20210015
Sep 20210013
Oct 202196049
Nov 2021186044
Dec 2021172014
Jan 2022168023
Feb 202281011
Mar 2022168019
Apr 2022170030
Total19880393